We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$13.7B
AUM Growth
+$2.27B
Cap. Flow
+$2.05B
Cap. Flow %
14.94%
Top 10 Hldgs %
20.25%
Holding
4,072
New
258
Increased
1,574
Reduced
1,252
Closed
284

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$166M
2
NVDA icon
NVIDIA
NVDA
+$72.4M
3
IVW icon
iShares S&P 500 Growth ETF
IVW
+$59.8M
4
AAPL icon
Apple
AAPL
+$43.5M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$35.6M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$28.6M
2
SPTI icon
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
+$18M
3
MCD icon
McDonald's
MCD
+$15.5M
4
IBDX icon
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
+$8.45M
5
SHM icon
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
+$6.17M

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Financials 5.84%
3 Healthcare 5.21%
4 Consumer Discretionary 4.33%
5 Industrials 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
3651
Cardiff Oncology
CRDF
$66.2M
$180 ﹤0.01%
81
– –
ONTF
3652
DELISTED
ON24
ONTF
$180 ﹤0.01%
+30
New +$191
AXGN icon
3653
Axogen
AXGN
$2.22B
$178 ﹤0.01%
25
-75
-75% -$513
GRND icon
3654
Grindr
GRND
$3.01B
$171 ﹤0.01%
+14
New +$140
DNMR
3655
DELISTED
Danimer Scientific, Inc.
DNMR
$171 ﹤0.01%
7
+2
+40% +$62
RUSHA icon
3656
Rush Enterprises Class A
RUSHA
$6.21B
$169 ﹤0.01%
4
– –
KODK icon
3657
Kodak
KODK
$819M
$167 ﹤0.01%
31
– –
AKRO
3658
DELISTED
Akero Therapeutics
AKRO
$164 ﹤0.01%
+7
New +$150
ADPT icon
3659
Adaptive Biotechnologies
ADPT
$3.85B
$163 ﹤0.01%
45
– –
EWTX icon
3660
Edgewise Therapeutics
EWTX
$4.42B
$162 ﹤0.01%
+9
New +$157
DOMO icon
3661
Domo
DOMO
$174M
$154 ﹤0.01%
20
-50
-71% -$374
GRPN icon
3662
Groupon
GRPN
$1.06B
$153 ﹤0.01%
10
– –
AEVA
3663
Aeva Technologies
AEVA
$1.13B
$151 ﹤0.01%
60
– –
KNX icon
3664
Knight Transportation
KNX
$11.4B
$151 ﹤0.01%
3
-74
-96% -$3.62K
ALEC icon
3665
Alector
ALEC
$180M
$145 ﹤0.01%
32
– –
MCRB icon
3666
Seres Therapeutics
MCRB
$46.3M
$145 ﹤0.01%
+10
New +$167
MNTS icon
3667
Momentus
MNTS
$85.1M
$136 ﹤0.01%
+1
New +$130
CLBK icon
3668
Columbia Financial
CLBK
$1.14B
$135 ﹤0.01%
+9
New +$140
VUZI icon
3669
Vuzix
VUZI
$194M
$135 ﹤0.01%
+100
New +$138
IRMD icon
3670
iRadimed
IRMD
$1.22B
$132 ﹤0.01%
+3
New +$128
WKHS icon
3671
Workhorse Group
WKHS
$34.5M
$131 ﹤0.01%
+1
New +$524
EGIO
3672
DELISTED
Edgio, Inc. Common Stock
EGIO
$131 ﹤0.01%
12
– –
SPRO icon
3673
Spero Therapeutics
SPRO
$69.5M
$130 ﹤0.01%
100
– –
MLNK
3674
DELISTED
MeridianLink
MLNK
$128 ﹤0.01%
+6
New +$112
BBC icon
3675
Virtus Biotech Clinical Trials ETF
BBC
$47.8M
$126 ﹤0.01%
5
– –
145 146
147
148 149

Similar funds

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

NewEdge Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, NewEdge Advisors held 4,072 positions worth $13.7B, up 20% from $11.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

NewEdge Advisors deployed $2.05B of net new capital in Q2 2024, opening 258 new positions and adding to 1,574 existing holdings. Its largest new stake was AB Short Duration High Yield ETF: 560,020 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novartis, an estimated $28.6M trimmed.

  • NewEdge Advisors's largest Q2 2024 buy was AB Short Duration High Yield ETF: 560,020 shares worth $19.7M.
  • NewEdge Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $166M increase.
  • NewEdge Advisors's biggest Q2 2024 reduction was Novartis, cutting an estimated $28.6M.
  • NewEdge Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.96M.
  • NewEdge Advisors's ten largest holdings make up 20% of its $13.7B portfolio in Q2 2024.
  • NewEdge Advisors opened 258 new positions and closed 284 in Q2 2024.
  • NewEdge Advisors's portfolio value rose 20% quarter-over-quarter to $13.7B.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.